Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
ETHINYLESTRADIOL (AS BETADEX-CLATHRATE) DROSPIRENONE
Bayer Limited
ETHINYLESTRADIOL (AS BETADEX-CLATHRATE) DROSPIRENONE
0.020+3.00 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
Withdrawn
0000-00-00
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rimendia 0.02mg/3mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 24 light pink film-coated tablets: Each film-coated tablet contains 0.020 mg ethinylestradiol (as betadex clathrate) and 3 mg drospirenone. Excipient: lactose 46 mg 4 white placebo (inactive) film-coated tablets: The tablet does not contain active substances. Excipient: lactose 50 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet The active tablet is light pink, round with convex faces, one side embossed with the letters "DS" in a regular hexagon. The placebo tablet is white, round with convex faces, one side embossed with the letters "DP" in a regular hexagon. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Oral contraception. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration: oral use HOW TO TAKE RIMENDIA The tablets must be taken every day at about the same time, if necessary with a little liquid, in the order shown on the blister pack. Tablet taking is continuous. One tablet is to be taken daily for 28 consecutive days. Each subsequent pack is started the day after the last tablet of the previous pack. Withdrawal bleeding usually starts on day 2-3 after starting the placebo tablets (last row) and may not have finished before the next pack is started. HOW TO START RIMENDIA o preceding hormonal contraceptive use (in the past month) Tablet-taking has to start on day 1 of the woman’s natural cycle (i.e. the first day of her menstrual bleeding). - Changing from a combined hormonal contraceptive (combined oral contraceptive (COC), vaginal ring or transdermal patch) IRISH MEDICINES BOARD ________________________________________________________________________________________ Baca dokumen lengkap